Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | -1.18% | +2.45% | +42.74% |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Mar. 18 | Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer | CI |
Financials (USD)
Sales 2024 * | 2.74M | Sales 2025 * | 7.36M | Capitalization | 125M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -43M | EV / Sales 2024 * | 37.7 x |
Net cash position 2024 * | 21.26M | Net Debt 2025 * | 12.33M | EV / Sales 2025 * | 18.6 x |
P/E ratio 2024 * |
-3.17
x | P/E ratio 2025 * |
-2.88
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.88% |
Latest transcript on Clearside Biomedical, Inc.
1 day | -1.18% | ||
1 week | +2.45% | ||
Current month | +19.29% | ||
1 month | +19.71% | ||
3 months | +41.53% | ||
6 months | +94.19% | ||
Current year | +42.74% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 1.67 | -1.18% | 520,766 |
24-03-26 | 1.69 | -2.31% | 203,662 |
24-03-25 | 1.73 | +1.17% | 183,965 |
24-03-22 | 1.71 | -5.00% | 247,363 |
24-03-21 | 1.8 | +10.43% | 571,700 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.74% | 125M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.60% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |